If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
<br /> September/October 2009 ISSN 1746-174X Volume 5 Number 5<br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> The global magazine for the pharmaceutical and biopharmaceutical industry<br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> Quality Considerations fo<br /> <br /> SHOW<br /> SPECIAL<br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> PEPTIDE PRODUCTION<br /&g
September/October 2009 ISSN 1746-174
September/October 2009 ISSN 1746-174
IT'SALLstrap goes here www.pharma-mag.comABOU
IT'SALLstrap goes here www.pharma-mag.comABOU
sEPTEMBER/OCTOBER09ThE PlaCE TO gaThERCPhI/ICSE
sEPTEMBER/OCTOBER09ThE PlaCE TO gaThERCPhI/ICSE
Contributing EditorGraham Lampard+44 774 370 48
Contributing EditorGraham Lampard+44 774 370 48
Sophisticated product formulationslead to pack
Sophisticated product formulationslead to pack
forewordwww.pharma-mag.comThE QP ExPlaINEDAnn
forewordwww.pharma-mag.comThE QP ExPlaINEDAnn
requirement doesn’t yet apply to APIs that areus
requirement doesn’t yet apply to APIs that areus
CPhi newswww.pharma-mag.comThE PlaCE fORNETwO
CPhi newswww.pharma-mag.comThE PlaCE fORNETwO
Brecon’s Unique Outsourcing PropositionHall 8, G
Brecon’s Unique Outsourcing PropositionHall 8, G
CPhi newswww.pharma-mag.comBu
CPhi newswww.pharma-mag.comBu
BI Lung Cancer trialsHall 3, D28Boehringer Inge
BI Lung Cancer trialsHall 3, D28Boehringer Inge
www.breconpharm.comServing the
www.breconpharm.comServing the
Complete Pipeline PartnerHall 3 B56SAFC Pharma
Complete Pipeline PartnerHall 3 B56SAFC Pharma
eOA previewwww.pharma-mag.comEOa 2009
eOA previewwww.pharma-mag.comEOa 2009
Buildyourproductst’rsapsugocecsehesrse
Buildyourproductst’rsapsugocecsehesrse
eOA previewwww.pharma-mag.comSuccess in the
eOA previewwww.pharma-mag.comSuccess in the
strap goes herewww.pharma-mag.com
strap goes herewww.pharma-mag.com
eOA previewwww.pharma-mag.com
eOA previewwww.pharma-mag.com
IF NAL STSIEOA previewwww.phar ma-mag.c
IF NAL STSIEOA previewwww.phar ma-mag.c
drug deliverywww.pharma-mag.comCustomized Adhe
drug deliverywww.pharma-mag.comCustomized Adhe
drug deliverywww.pharma-mag.comAdhesive D
drug deliverywww.pharma-mag.comAdhesive D
drug deliverywww.pharma-mag.com
drug deliverywww.pharma-mag.com
WE’LL ALWAYS BE… CLOSE TO YOUSGS Life
WE’LL ALWAYS BE… CLOSE TO YOUSGS Life
EVERYTHING YOU NEED, NOTHING YOU DON’T
EVERYTHING YOU NEED, NOTHING YOU DON’T
When you find us, you’ll discover a world-leading
When you find us, you’ll discover a world-leading
supply chainwww.pharma-mag.comPhaRMa INDUs
supply chainwww.pharma-mag.comPhaRMa INDUs
the situation “is a hazard to public health. It i
the situation “is a hazard to public health. It i
drug discoverywww.pharma-mag.comThE aDOPTION O
drug discoverywww.pharma-mag.comThE aDOPTION O
Figure 2: Workflow for the screening of Fab phage
Figure 2: Workflow for the screening of Fab phage
drug discoverywww.pharma-mag.com
drug discoverywww.pharma-mag.com
BIOQUELL® bio-decontamination
BIOQUELL® bio-decontamination
drug discoverywww.pharma-mag.comUsINg Mass DEf
drug discoverywww.pharma-mag.comUsINg Mass DEf
the user to identify multiple metabolites of inte
the user to identify multiple metabolites of inte
drug discoverywww.pharma-mag.com
drug discoverywww.pharma-mag.com
WORLD-CLASS CONTRACT MANUFACTURING ORGANISATION s
WORLD-CLASS CONTRACT MANUFACTURING ORGANISATION s
Visit us atCPhI Madrid 2009 Stand 6C14
Visit us atCPhI Madrid 2009 Stand 6C14
FILM FORMING AND COATING POLYMERS F
FILM FORMING AND COATING POLYMERS F
business strategy www.pharma-mag.comGettinG Ah
business strategy www.pharma-mag.comGettinG Ah
upcoming product at the expense of other viablec
upcoming product at the expense of other viablec
clinical trialswww.pharma-mag.comthe future of
clinical trialswww.pharma-mag.comthe future of
About the AuthorMichael Federico, Vice President
About the AuthorMichael Federico, Vice President
drug development www.pharma-mag.comStAYinG on
drug development www.pharma-mag.comStAYinG on
• Analytical methods must be developed and valida
• Analytical methods must be developed and valida
drug development www.pharma-mag.comthe contr
drug development www.pharma-mag.comthe contr
and request that the limits be tightened. It is i
and request that the limits be tightened. It is i
strap goes herewww.pharma-mag.comBLOW-FILL-SEAL
strap goes herewww.pharma-mag.comBLOW-FILL-SEAL
quality controlwww.pharma-mag.comQuAlitYConSi
quality controlwww.pharma-mag.comQuAlitYConSi
quality controlwww.pharma-mag.comsupply syst
quality controlwww.pharma-mag.comsupply syst
strap goes herewww.pharma-mag.comElectron
strap goes herewww.pharma-mag.comElectron
strap goes herewww.pharma-magPHARMA – MAY-JUNE
strap goes herewww.pharma-magPHARMA – MAY-JUNE
cleanroomswww.pharma-mag.comCleAnroom Cl
cleanroomswww.pharma-mag.comCleAnroom Cl
cleanroomswww.pharma-mag.comCategory
cleanroomswww.pharma-mag.comCategory
Law Regulation ExtractArbSchG (German
Law Regulation ExtractArbSchG (German
cleanroomswww.pharma-mag.com Protective Cloth
cleanroomswww.pharma-mag.com Protective Cloth
9th Annual
9th Annual
russian overviewwww.pharma-mag.comoperAtinG
russian overviewwww.pharma-mag.comoperAtinG
drug registration, strategic and marketing planni
drug registration, strategic and marketing planni
russian overviewwww.pharma-mag.com
russian overviewwww.pharma-mag.com
innovationwww.pharma-mag.comBuildinG onexCelle
innovationwww.pharma-mag.comBuildinG onexCelle
Global End User Application Director, Excipients,
Global End User Application Director, Excipients,
innovationwww.pharma-mag.com
innovationwww.pharma-mag.com
Bringing outsourcing to CPhIICSE - the Internat
Bringing outsourcing to CPhIICSE - the Internat
innovationwww.pharma-mag.comand instead look
innovationwww.pharma-mag.comand instead look
We have always worked Yours.to the highest stand
We have always worked Yours.to the highest stand
economicswww.pharma-mag.comAn innovAtivefinAnC
economicswww.pharma-mag.comAn innovAtivefinAnC
SEDA FactsheetA Standby Equity Distribution Agre
SEDA FactsheetA Standby Equity Distribution Agre
cphi showcase www. harma-ma .c
cphi showcase www. harma-ma .c
CPhIshowcasewww.pharma-mag o
CPhIshowcasewww.pharma-mag o
pr duct howcase o swww.pharm
pr duct howcase o swww.pharm
stra goerand Equipme t E ent. To r
stra goerand Equipme t E ent. To r
Advertorialstrap goes herewww.pharma-mag.com
Advertorialstrap goes herewww.pharma-mag.com
sales and marketingwww.pharma-mag.comph A BrA
sales and marketingwww.pharma-mag.comph A BrA
nostrapharmuswww.pharma-mag.comneedS + opportu
nostrapharmuswww.pharma-mag.comneedS + opportu
strap goes here
strap goes here
A quantum leap in Flow Rateand Throughput. New
A quantum leap in Flow Rateand Throughput. New